Official UK procurement notice
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
Authority: NHS England (Central government)
What is being bought2 lots · detail below
Published requirement descriptionNHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East.
Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.
Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
CPV: Pharmaceutical products
How this framework works
From the published notice- Type
- Open framework
- Call-offs
- every call-off is a further competition among the appointed suppliers
- Bids received
- 25 bids on the busiest of 2 lots · 25 suppliers appointed
- Framework period
- 2 yrs · up to 4 yrs from 1 Sept 2026
Who may buy through it
Please refer to Document No. 09 of the ITO Documents for the list of Participating Authorities/Pharmacy Purchasing Points
Published description of the framework
Please refer to the ITO Documents for the Operation Description
Lots and requirements (2)Procurement structure
2 lots · all with a published valueLot #1CM/PHR/25/5730/01 - Tranche B for NOFE and MAEAwardedRenewalPublished value£846,138,512
Lot 1 - Tranche A for the North of England and Midlands & East.
Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.
Lot #2CM/PHR/25/5730/02 - Natalizumab for London & SOFEAwardedRenewalPublished value£31,532,058
Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement : 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- “NHS Branded Medicines Tranche A - NOFE and Midlands & East and…” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use the vehicle
- Please refer to Document No. 09 of the ITO Documents for the list of Participating Authorities/Pharmacy Purchasing Points
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 22 May 2025, 09:34 BST
- Last source update
- 21 Jul 2026, 11:16 BST
- Award evaluation window
- Submission end – 5 Jun 2026
- Authority reference
C414060- FTS notice number
2026/S 000-023990- Latest notice
- Contract details notice (UK7)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-051c98Find a Tender
How it was run
Official notice- Appointment period ends
- 17 Apr 2026, 13:00 BST
- Clarification deadline
- 10 Apr 2026, 17:00 BST
- Submission channel
- Official e-sourcing portal
- Electronic submission
- Allowed
- Accepted languages
- en
The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗
Additional info obtained from the abovementioned address. Tenders must be submitted to the abovementioned address
Timeline
22 May 2025 → 1 Sept 2026 · 11 dates- Planning notice published22 May 2025, 09:34 BST
- Market engagement260 days ago28 Jan 2026, 23:59 GMT
NHS England is advising suppliers of an upcoming tender for the NHS Branded Framework Agreement – Tranche A for the North of England and Midlands & East.
Period of Framework Agreement (Lot 1): 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.
There will be a separate Lot to provide framework agreement coverage to the London and South of England regions for Natalizumab. The period of Framework Agreement (Lot 2): 1st September 2026 to 31st August 2027 with the option or option(s) to extend for a further 12 months.
Eight category areas are covered in Tranche A: Erythropoietin Stimulating Agents, Granulocyte-Colony Stimulating Factor (GCSF), Insulin Analogues, MS Drugs, Parenteral Iron, Severe Asthma, Severe Asthma/Interleukin Inhibitor and Teriparatide.
The purpose of this notice is to inform existing and potential new suppliers that if NHS England believe that it would be beneficial a virtual 1:1 preliminary market meeting can be arranged. Please contact [email protected] to register your interest. There will also be a 14 day window for queries to be raised via Atamis after all sessions have concluded.
- Tender notice published213 days ago17 Mar 2026, 12:14 GMT
- Next notice expected212 days ago17 Mar 2026, 23:59 GMT
- Clarification questions by189 days ago10 Apr 2026, 17:00 BST
- Admission / appointment period ends182 days ago · period end, not a bid countdown17 Apr 2026, 13:00 BST
- Award decision expected by132 days ago5 Jun 2026, 23:59 BST
- Assessment summaries sent115 days ago23 Jun 2026, 00:00 BST
- Standstill ends105 days ago2 Jul 2026, 23:59 BST
- Latest notice published87 days ago21 Jul 2026, 11:16 BST
- Contract starts45 days ago1 Sept 2026, 00:00 BST
Notice history
15 events · 8 releases on Find a Tender · since 22 May 2025- Pipeline notice published22 May 2025, 09:34 BSTUK1
- Pipeline notice published3 Jun 2025, 12:41 BSTUK1
- Preliminary market engagement notice published13 Jan 2026, 09:57 GMTUK2
- Published value updated to £456,000,00013 Jan 2026, 09:57 GMTwas £206,835,684
- Preliminary market engagement notice published13 Mar 2026, 15:08 GMTUK2
- Tender notice published17 Mar 2026, 12:14 GMTUK4
- Published value updated to £877,670,57017 Mar 2026, 12:14 GMTwas £456,000,000
- Status changed to active17 Mar 2026, 12:14 GMT
- Procurement method changed17 Mar 2026, 12:14 GMT
- Deadline published: 17 Apr 2026, 13:00 BST17 Mar 2026, 12:14 GMT
- Contract award notice published23 Jun 2026, 12:33 BSTUK6
- Status changed to complete23 Jun 2026, 12:33 BST
- Contract signature expected6 Jul 2026, 23:59 BSTscheduled
- Contract award notice published9 Jul 2026, 15:45 BSTUK6
- Contract details notice published21 Jul 2026, 11:16 BSTUK7
Published amendments (2)
Updated to Above Threshold Tender
Date for Tender Registration Updated
Routine re-releases (8)
- 2026-03: 2 releases · 13 Mar 2026, 17 Mar 2026
- 2026-01: 1 release · 13 Jan 2026
- 2025-06: 1 release · 3 Jun 2025
- 2025-05: 1 release · 22 May 2025
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Lot 1 · CM/PHR/25/5730/01 - Tranche B for NOFE and MAE1 award | |||
| ACCORD-UK LTD, Biogen Idec Ltd, Cipla EU Limited, GLAXOSMITHKLINE UK LIMITED, Gedeon Richter UK Ltd, Novo Nordisk Limited +19 moreLot 1 - CM/PHR/25/5730/01 - NHS Branded Medicines Tranche A for Midlands & East1 Sept 2026 – 31 Aug 2028 · up to 31 Aug 2030Extensions: With an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months · Options: With an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 · Amended: Lot 1 Tender Values Incorrect | £665,389,588 | 15 Jun 2026standstill to 2 Jul 2026 | Standstill |
| Lot 2 · CM/PHR/25/5730/02 - Natalizumab for London & SOFE1 award | |||
| Biogen Idec Ltd, SandozLot 2 - CM/PHR/25/5730/02 - Natalizumab for London & South of England1 Sept 2026 – 31 Aug 2027 · up to 31 Aug 2028Extensions: With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months · Options: With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months · Amended: Lot 1 Tender Values Incorrect | £35,312,548 | 15 Jun 2026standstill to 2 Jul 2026 | Standstill |
Contracts
Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
- Signed
- 6 Jul 2026
- Value
- £665,389,588
- Period
- 1 Sept 2026 – 31 Aug 2028 · up to 31 Aug 2030 with extensions
- Status
- active
- Extensions
- With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
- Options
- With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
Lot 2 - CM/PHR/25/5730/02 - Natalizumab for London and South of England
- Signed
- 6 Jul 2026
- Value
- £35,312,548
- Period
- 1 Sept 2026 – 31 Aug 2027 · up to 31 Aug 2028 with extensions
- Status
- active
- Extensions
- With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
- Options
- With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | 25final-stage tenders | 6 | 0 | — |
| 2 · CM/PHR/25/5730/02 - Natalizumab for London & SOFE | 2final-stage tenders | 0 | 0 | — |
Who bid
- did not winAVENTIS PHARMA LIMITED t-a Sanofi · South East England · 1
- wonACCORD-UK LTD · South West England · 1
- did not winAMGEN LIMITED · East of England · 1
- did not winBAYER PLC · South East England · 1
- wonBIOGEN IDEC LIMITED · South East England · all lots
- did not winCHUGAI PHARMA LIMITEDSME · Greater London · 1
- wonCIPLA (EU) LIMITED · South East England · 1
- did not winCST PHARMA LIMITEDSME · West Midlands · 1
- did not winELI LILLY & COMPANY LTD · South East England · 1
- wonGEDEON RICHTER (UK) LIMITEDSME · Greater London · 1
- wonGLAXOSMITHKLINE UK LIMITED · Greater London · 1
- did not winLABORATORIES JUVISE PHARMACEUTICALS · 1
- did not winMERCK SERONO LIMITED · Greater London · 1
- did not winMILPHARM LIMITED · Greater London · 1
- did not winNAPP PHARMACEUTICALS LTD · East of England · 1
- wonNOVO NORDISK · South East England · 1
- wonORIFARM UK LTDSME · East of England · 1
- did not winPFIZER LIMITED · South East England · 1
- did not winPHARMACOSMOS UK LTDSME · South East England · 1
- did not winROCHE PRODUCTS LIMITED · East of England · 1
- wonSANDOZ LIMITED · South East England · all lots
- did not winTEVA UK LIMITED · Yorkshire and the Humber · 1
- did not winTHORNTON & ROSS LIMITED · Yorkshire and the Humber · 1
- did not winVIATRIS UK HEALTHCARE LTD · East of England · 1
- wonVIFOR PHARMA UK LTDSME · Greater London · 1
Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.
Contracting authority & participating public bodies
Framework contractors & participating bidders
27 commercial parties on the notice- ACCORD-UK LTDFramework contractor
- AMGEN LIMITEDFramework contractor
- AVENTIS PHARMA LIMITED t-a SanofiFramework contractor
- BAYER PLCFramework contractor
- BAYER PLCFramework contractor
- BIOGEN IDEC LIMITEDFramework contractor
- CHUGAI PHARMA LIMITEDFramework contractor
- CIPLA (EU) LIMITEDFramework contractor
- CST PHARMA LIMITEDFramework contractor
- ELI LILLY & COMPANY LTDFramework contractor
Show 17 more suppliers
- GEDEON RICHTER (UK) LIMITEDFramework contractor
- GLAXOSMITHKLINE UK LIMITEDFramework contractor
- LABORATORIES JUVISE PHARMACEUTICALSFramework contractor
- MERCK SERONO LIMITEDFramework contractor
- MILPHARM LIMITEDFramework contractor
- NAPP PHARMACEUTICALS LTDFramework contractor
- NOVO NORDISKFramework contractor
- NOVO NORDISKFramework contractor
- ORIFARM UK LTDFramework contractor
- PFIZER LIMITEDFramework contractor
- PHARMACOSMOS UK LTDFramework contractor
- ROCHE PRODUCTS LIMITEDFramework contractor
- SANDOZ LIMITEDFramework contractor
- TEVA UK LIMITEDFramework contractor
- THORNTON & ROSS LIMITEDFramework contractor
- VIATRIS UK HEALTHCARE LTDFramework contractor
- VIFOR PHARMA UK LTDFramework contractor
Official documents & specifications (30)
Official links; attachments are not copiedTender pack and attachments
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Signed contract
- Signed contract
- Signed contract
Show 10 more documents
- Signed contract
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
Notices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Tender notice Tender notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
Show 3 more notices
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Pipeline notice Pipeline notice on Find a Tender
- Pipeline notice Pipeline notice on Find a Tender
1 further documents are listed in the JSON mirror.